Form 4: United Therapeutics Director Exercises Options and Sells Shares
SEC Form 4 Filing
Christopher Causey, a director at United Therapeutics, exercised stock options and sold shares on June 18, 2024.
Summary
- On June 18, 2024, Christopher Causey, a director of United Therapeutics Corporation, exercised stock options to acquire 3,000 shares of common stock at a price of $112.14 per share.
- Simultaneously, Causey sold 3,000 shares of common stock at a weighted average price of $304.1795, with prices ranging from $304.03 to $304.19.
- Following these transactions, Causey directly owns 4,185 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event; a director exercising options and selling shares is a common occurrence and doesn't necessarily indicate a positive or negative outlook.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 06/26/2019 | Date stock options were exercisable |
| 06/18/2024 | Date of stock option exercise and share sale |
| 06/20/2024 | Date of signature on the Form 4 filing |
| 06/26/2028 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.